2.2 ml, and CSF pressure fell from 35 to 19 cm HzO. With continued hypocapnia, CBV rose to 2.8 ml by 4 h, but CSF volume fell from 6. 1 to 5.0 ml, so that CSF pressure remained low. Net intracranial absorption of CSF did not exceed net intracranial CSF production, suggesting that CSF volume fell because hypocapnia improved access of intracranial CSF to spinal sites of CSF reabsorption. Brain tissue composition was not different among groups.
The results indicate that hypocapnia lowers elevated CSF pressure initially by lowering CBY. This CSF pressure lowering effect is sustained (despite reexpansion of CBV) by a further reduction of CSF volume. In this model, brain tissue water or electrolytes did not contribute to changes in CSF pressure. Key Words: Brain tissue elec trolytes-Cerebral blood volume-Cerebral edema Cerebrospinal fluid, pressure, volume-Hypocapnia. Lammertsma et aI., 1983b) , it is believed that de crease of CBV may contribute to the reduction of CSF pressure caused by hypocapnia. However, ad aptation to the CBF-reducing effect of hypocapnia occurs with time, so that by 4-16 h, CBF returns to prehypocapnia values (Raichle et aI., 1970) . It is not certain whether or not normalization of CBF that occurs during prolonged hypocapnia is accom panied by reexpansion of CBV and, if so, what the time course of normalization of CBV might be.
Another means by which hypocapnia may lower CSF pressure is by reducing CSF volume. CSF volume would decrease if hypocapnia either re duced the rate of formation of CSF (Vf) or in creased the rate of reabsorption of CSF (Va)' Pre vious studies suggest that hypocapnia may produce a transient decrease of Vf (Ames et aI., 1965) , but after 30-60 min, Vf returns to prehypocapnia values (Martins et aI., 1976; Hochwald et aI., 1976; Artru and Hornbein, 1987) . The effects of hypo-capnia on Va have not been examined. Hypocapnia may increase Va either by improving the access of CSF to outflow channels (reversing structural dis tortions caused by high CSF pressure) or by im proving the conductance through outflow channels.
A third means by which hypocapnia may lower CSF pressure is by reducing brain tissue volume. Increase of brain tissue volume generally results from increase of brain tissue water content. Such cerebral edema occurs either because cerebral vessels become distended and more permeable, or because of regional insufficiency of CBF, impairing the energy-dependent mechanisms that preserve normal fluid and electrolyte gradients (Langfitt et aI., 1964; Lassen, 1966; Klatzo, 1967; Siesjo et aI., 1967) . Hypocapnia may reverse cerebral edema by reversing cerebral vascular distention or by im proving regional distribution of CBF (Gordon and Rossanda, 1968) .
The present study examines the effect of hypo capnia on elevated CSF pressure caused by an in tracranial mass. The contribution of CBV, CSF volume, and brain tissue water and electrolytes to CSF pressure changes was determined during 4 h of hypocapnia following �2 h of elevated CSF pres sure and normocapnia.
METHODS

Surgical preparation
Eighteen unmedicated mongrel dogs (weighing 14-2 1 kg) were studied. Anesthesia was induced with halothane (> 1.3% inspired) in nitrous oxide (N20, 60-70%) and ox ygen. The trachea was intubated, and ventilation was controlled to maintain initial blood gases (Radiometer BMS3 Mk2 electrodes) at Pao2 > 120 mm Hg and Paco2 35-40 mm Hg. The right femoral artery was cannulated to permit arterial blood sampling for blood gas analysis and to permit continuous monitoring of systemic arterial pressure and heart rate. Mean arterial pressure (MAP) was determined by electronic integration. A urinary cath eter was placed, the right femoral vein was cannulated for fluid and drug administration, expired CO2 was contin uously monitored, and temperature was monitored by a nasopharyngeal thermister probe. Surgical preparations for determination of CBV and CSF values were made as follows.
CBV was determined by measuring gamma ('Y) emis sion from intravenously injected iodinated I3lI-albumin (RISA) (Risberg and Ingvar, 1968; Risberg et aI., 1969) (Albumotope; ER Squibb and Sons, Inc., Princeton, NJ, U.S.A.). A midline scalp incision was made, and the muscles were reflected laterally. Over the right parietal region, the skull was thinned around the perimeter of a 4
x 5 cm area to expose diploic veins, which were then occluded with bone wax. A converging (5-inch focal length) collimated scintillation probe (Nal) was placed over the exposed region at right angles to the head and 60° from horizontal. The "window" of the detector (Picker Nuclear Magnascanner 500) was set at 250-450 Ke V, and the time constant was set at 20 s. Sufficient RISA was injected intravenously to provide counting rates of 1,500-2,500 cpm. Ninety minutes were allowed for equilibration of RISA prior to beginning the experi mental phase. CSF values were determined by closed ventriculocis ternal perfusion. A burr hole was placed over the left hemisphere, and a cannula was directed into the under lying lateral ventricle. The posterior neck muscles were surgically separated to expose the atlanto-occipital mem brane, and a cannula was directed into the cisterna magna. A T-connector was attached to each cannula, and CSF pressures were measured by attaching one arm of the T-connector to a strain gauge transducer. A 0.3-ml sample of CSF was obtained from the cisternal cannula for measurement of osmolality using a Wescor Model 5100 B Vapor Pressor Osmometer (Wescor, Inc., Logan, UT, U.S.A.). Mock CSF of matching osmolality was pre pared by mixing standard solutions (Davson, 1970) (os molality 290, 300, or 310 mosmollkg) labeled with Blue Dextran (1 mg/mt) (Sigma Chemical Co., St. Louis, MO, U.S.A.).
Mock CSF was infused into the ventricle through the second arm of the ventricular T-connector, and the mix ture of mock and native CSF was withdrawn from the cisterna magna through the second arm of the cisternal T-connector using a Harvard dual-syringe pump (Har vard Infusion/Withdrawal Pump model 94 1; Harvard Ap paratus, South Natick, MA, U.S.A.). The flow-through cuvette of a Tu rner spectrophotometer (model 330; Tu rner Associates, Palo Alto, CA, U.S.A.) was posi tioned in the withdrawal line. The infusion and with drawal rates were 30 I.d/min. Ventricular and cisternal CSF pressures were monitored continuously to insure that pressures did not change significantly from preperfu sion values. One hundred and twenty minutes of ventri culocisternal perfusion was allowed for equilibration of labeled mock CSF with native CSF in the intracerebral and cisternal CSF spaces of the dog prior to determining CSF volume, Vf, and Va' The concentration of Blue Dex tran in the cisternal outflow solution was determined continuously as the solution passed through the in-line flow-through cuvette. Concentrations of Blue Dextran were determined using light absorbence at 620 nm. Light absorbence values from the spectrophotometer were re corded continuously on a Gould polygraph so that at any moment it could be determined whether the displayed light absorbance value was truly representative or a mo mentary fluctuation. Details of this technique were pre viously reported (Artru and Hornbein, 1986) .
Experimental phase
Upon completion of the surgical preparation, wound edges were infiltrated with bupivacaine (0.75%), and the concentration of halothane was decreased to 0. 15% (end expired value determined intermittently by gas chroma tography). After systemic variables had stabilized (�30 min), dogs were assigned to one of three groups. In group I (n = 6), there were no further interventions until the start of the experimental period. In groups II (n = 6) and III (n = 6), a burr hole was placed over the right fronto parietal region, and a balloon-tipped catheter was in serted between the dura and the skull. The catheter bal loon was inflated with air to increase ventricular CSF pressure to 35 cm H20. Over the next 15-20 min, small additional amounts of air were added to maintain ventric-ular CSF pressure at the desired value. The total volume of air infused was recorded and compared to the volume of air retrieved from the balloon-tipped catheter at the conclusion of the study. CSF remained close to 35 cm HP until the start of the experimental period without further alteration of balloon volume. CSF pressure re mained elevated for about 105 min prior to beginning the experimental phase.
The experimental period began after the periods of equilibration for RISA and Blue Dextran. All cerebral and systemic values were determined (time 0). Then, in groups I (no intracranial mass) and III (intracranial mass present), Paco2 was reduced to 20 mm Hg by hyperventi lation. Hypocapnia was not induced in group II (intra cranial mass present). All cerebral and systemic values were determined at 10 min, at 30 min, and every 30 min thereafter up to 240 min.
During the experimental phase, 'Y emission from the head was determined continuously and displayed on a multichannel Gould polygraph. In order to determine CBV, it was necessary to relate 'Y emission from the head to 'Y activity per unit volume of blood. This was done as follows. Samples of femoral arterial blood were taken at IO min, at 30 min, and every 30 min thereafter during the experimental phase. The 'Y activity per milliliter of blood was determined for each sample using a well-type scintil lation counter (Auto-Gamma Scintillation Spectrometer, model 90 11, United Te chnologies Packard, Santa Ana, CA, U.S.A.). After the 240-min sampling, several grams of brain tissue was rapidly excised from the cerebral cortex near the site of the balloon-tipped catheter and from a site on the contralateral cortex. Several specimens of gray and white matter were taken from each brain tissue sample for determination of regional CBV (rCBV). Gray and white matter rCBV was determined from spec imen weight, the 'Y emission of the specimen, as deter mined in the well-type scintillation counter, and the 'Y ac tivity per milliliter of systemic blood. Correction for the difference between the red blood cell/plasma ratio of ce rebral blood and the red blood cell/plasma ratio of sys temic blood was made using the conventional value of 0.85.
Before CBV could be calculated from rCBV values, it was also necessary to relate 'Y emission from the head to 'Y emission from intracerebral blood. In the present model, total 'Y emission detected by the scintillation probe derives primarily from intracerebral blood, with some contribution from both background activity and ex tracranial blood on the opposite side of the head from the probe. Correction for extracerebral 'Y emission was done as follows. After obtaining brain tissue specimens, the dog was killed by intravenous injection of potassium chloride, and a neck tourniquet was tightened. The entire cerebrum was excised and weighed, and the 'Y emission detected by the scintillation probe over the head was re corded. The 'Y emission with the brain removed was taken to represent 'Y emission from background and from extra cranial blood in tissues on the opposite side of the head from the scintillation probe. Intracranial 'Y emission was determined as the difference between total 'Y emission (prior to removal of brain) and 'Y activity from back ground and extracranial sources.
The value for CBV at 240 min was determined from intracranial 'Y emission (corrected 'Y emission detected by the scintillation probe), rCBV, and brain weight. CBV for the other periods of the experimental phase were calcu-lated based on CBV at 240 min, intracranial 'Y emission for each time period (corrected 'Y emission detected by the scintillation probe), and the 'Y activity per milliliter of blood for each time period.
CSF pressure in the lateral cerebral ventricle and the cisterna magna was continuously displayed on a multj channel Gould polygraph, along with total 'Y emission. Vr at each time period was determined as previously de scribed (Artru et aI., 1982) , according to the formula of Heisey et al. (1962) . CSF volume at the first time period of the experimental phase was determined as the volume of distribution (VDJ of Blue Dextran in the intracerebral and cisternal CSF spaces of the dog. VDx was determined according to the formula of Pappenheimer et al. (1962) . CSF volume at subsequent time periods was determined from initial CSF volume and interval change in CSF volume. Change in CSF volume was calculated from CSF volume, CSF pressure, and CBV according to the for mulas of Avezaat et al. (1979, 1980 ) (see Appendix). Va was determined from change in CSF volume and Vf (see Appendix). Resistance to reabsorption of CSF (Ra) was determined as the inverse of the slope relating Va to CSF pressure.
Brain tissue water, sodium (Na), and potassium (K) contents were determined from the end-study brain tissue specimens of gray and white matter that were not used to determine rCBY. Immediately following excision and sep aration, brain tissue specimens chosen for determination of water content were weighed (wet weight). Weights were corrected for the contribution by blood weight based on the rCBV of the paired specimens (see above). Specimens then were placed into a vacuum dessicator (Heated Va cuum Dessicator, Precision Scientific Co., Chicago, IL, U.S.A.) at 80°C for 5 days or until constant weight was achieved (dry weight). The percent water content of gray and white tissues was determined as corrected wet weight (g) -dry weight (g) corrected wet weight (g) Brain tissue specimens chosen for determination of Na and K contents were weighed, then placed in 5 ml of con centrated nitric acid for 24 h. The concentrations of Na and K in the resultant solution was determined by flame photometry (Flame Photometer, model 143, Instrumenta tion Laboratory, Inc., Lexington, MA, U.S.A.).
Statistical comparisons of percent brain tissue water, brain tissue Na and K, and systemic values within groups were made using repeated-measures analysis of variance, and comparisons between groups were made using one way analysis of variance. Where the calculated F value exceeded the critical value for the 0.05 probability level, the Student-Newman-Keuls's test was used to determine which differences :-vere �ignificant at p < 0.05. The rela tionship between Vr or Va and time, and between change of CSF pressure and change of intracranial volume (CBV plus CSF volume), was determined by linear regression analysis and computation of the correlation coefficient. The t statistic was used to determine whether or not the correlation coefficient was significant at p < 0.05. Com parisons of other cerebral values within and between groups were made using the Kruskal-Wallis test. Where the calculated X 2 value exceeded the critical value for the 0.05 probability level, the Mann-Whitney U-test was used to determine which differences were significant at p < 0.05. Cerebral values compared in this way were CSF pressure, CBV, CSF volume, median Vf, Va regression slopes, and median Ra.
RESULTS
When animals with an intracranial mass were made hypocapnic (group Ill), changes in CBV and CSF volume, but not brain tissue, contributed to changes in CSF pressure. During the first 10 min of hypocapnia, CBV fell by 0.6 ml (Table O. CSF volume increased by only 0.1 ml, so that CSF pres sure decreased by 15.3 cm H20. Reexpansion of CBV and a concomitant reduction of CSF volume occurred over the next 230 min of hypocapnia (Fig.  1) . By 240 min of hypocapnia, CBV had returned to prehypocapnia values, whereas CSF volume de creased by 1.1 ml. As a result, CSF pressure re mained well below prehypocapnia values. Thus, hypocapnia lowered elevated CSF pressure caused by an intracranial mass, initially by reducing CBV and later by reducing CSF volume.
When no intracranial mass was present and PaC02 was 35-40 mm Hg (group I), CBV was 3.4 ± 0.8 ml (mean ± SD), CSF volume was 6.5 ± 0.1 ml, and CSF pressure was 8.5 ± 1.7 cm H20. During the first 10 min of hypocapnia, CBV fell by 1.0 ml, but intracranial CSF volume increased by 1.1 ml, so that CSF pressure was not significantly altered. Reexpansion of CBV and a concomitant reduction of CSF volume occurred over the next 230 min of hypocapnia (Fig. 2) . By 240 min of hypocapnia, CBV and CSF volume had returned to prehypo capnia values. Throughout this period of hypo capnia, CSF pressure remained unchanged from prehypocapnia values. The presence of an intracranial mass (groups II and III) reduced CBV by 0.6-0.7 ml and CSF volume by 0.4-0.5 ml compared to values in an imals with no intracranial mass. Over the ensuing 240 min, CBV remained low (increase of 0.3 ml, NS), and CSF volume fell by 0.5 ml (Fig. 3 
) when
PaC02 was maintained at . 35-40 mm Hg (group II). As a result, CSF pressure remained elevated (de crease of 5 cm H20, NS).
During the study, V f did not change with time in any group, and there was no difference between groups with respect to median Vf. Va decreased significantly with time, and Va was greater with hy pocapnia and no intracranial mass (group I) than with intracranial mass present and either normo capnia or hypocapnia (groups II or III). Ra was greatest with normocapnia and intracranial mass present (group II) and least with hypocapnia and no intracranial mass (group I). The greatest reduction of CSF volume occurred with hypocapnia and in tracranial mass present (group III). The slope of the volume-pressure relationship was greater for nor mocapnia and intracranial mass present (group II) than for the other two groups.
At the end of the study, CSF pressure was highest with normocapnia and intracranial mass present (group II). CSF volume was least with hy pocapnia and intracranial mass present (group III). There were no differences between groups with re spect to CBY. Also, there were no differences be tween groups with respect to percent brain tissue water, brain tissue Na or K contents, or volume percent rCBV in either gray or white matter for ei ther the hemisphere with an intracranial mass present or the hemisphere with no intracranial mass (Table 2) . In every dog, the volume retrieved from the balloon-tipped catheter at the conclusion of the study equaled the volume initially infused.
Regarding systemic variables, hypocapnia de creased Paco2 and arterial blood bicarbonate and increased arterial blood pH ( 0.054 ± 0.005 0.050 ± 0.002
Brain tissue potassium (meq/g wet tissue)
0.089 ± 0.004 0.087 ± 0.004
Regional cerebral blood volume (%) 4.8 ± 0.8 3.3 ± 0.7 a Anesthetics: nitrous oxide (66%) and halothane (0.15%) in oxygen.
DISCUSSION
The results of this study indicate that when CSF pressure is elevated due to an intracranial mass, hypocapnia partially reverses the CSF pressure in crease and continues to do so for at least 4 h. Hy pocapnia initially lowered CSF pressure from ele vated values because CBV decreased. With time, CBV reexpanded despite continued hypocapnia. However, CSF pressure did not return to prehypo capnia values, as reexpansion of CBV was matched by contraction of intracranial CSF volume.
The time course of the cerebral vascular re sponse to hypocapnia observed here is consistent with previous reports on the cerebral vascular re sponses to hypocapnia when no intracranial mass and either no or mild brain injury was present. In those studies, hypocapnia reduced CBF or brain surface arteriole diameter within minutes (Raichle et aI., 1970; Christensen et aI., 1973a,b) . This initial cerebral vasoconstriction occurred because hypo capnia caused an alkalosis of brain extracellular fluid (ECF) (Wahl et aI., 1970; Pannier and Leusen, 1973; Lassen and Christensen, 1976) . Over the en suing 4-6 h, CBF returned to prehypocapnia values despite continued hypocapnia. Reexpansion of cerebral vessels is believed to result from adap tation of brain ECF pH (Raichle et aI., 1970) . At a constant level of hypocapnia, bicarbonate in brain ECF decreases with time, causing CSF pH to re turn toward normal (Hornbein and Pavlin, 1975) and, presumably, diminishing cerebral vasocon striction (Severinghaus, 1965) . Return of CBF to prehypocapnia values parallels adaptation of brain ECF pH (Severinghaus et aI., 1966; Fencl et aI., 1969; Pannier and Leusen, 1973) .
The present data relating to CSF dynamics permit inferences to be made about the mecha nisms of contraction of CSF volume. With hypo capnia and no intracranial mass (group I), Va was greater than Yr early after hypocapnia was begun. Va gradually declined, so that by 240 min of hypo capnia, Va matched Yr. During the 240 min of hypo capnia, cumulative intracranial absorption of CSF exceeded cumulative CSF production by about 0.9-1.0 mI. Thus, intracranial absorption of CSF accounted for 75-90% of the reduction of intra cranial CSF volume ( -1.1 m!) that accompanied the reexpansion of CBV during prolonged hypo capnia. Reabsorption of CSF at spinal sites pre sumably accounted for the remaining 10-25% re duction of CSF volume.
With an intracranial mass and normocapnia (group II), Va was greater than Vr initially, but was less than Yr by 240 min. For the entire experimental phase, cumulative intracranial CSF absorption ap proximately equalled cumulative CSF production. Thus, even though high CSF pressure existed, pro- viding a substantial "driving force" for intracranial reabsorption of CSF (Wood, 1980) , no net reab sorption of CSF at intracranial sites occurred. The presence of an intracranial mass appears to have distorted intracranial absorbance pathways, so that conductance at intracranial reabsorption sites was impaired. Some reduction of intracranial CSF volume ( -0.5 m!) did accompany the reexpansion of CBV (+ 0.3 m!) in this group. Outflow of CSF from the intracranial to the spinal space and reab sorption of CSF at spinal sites likely accounted for this reduction of intracranial CSF volume. That only a modest volume of intracranial CSF was reabsorbed via spinal sites despite high intracranial CSF pressure (substantial "driving force" for reab sorption) suggests that outflow of CSF from the in tracranial to the spinal space was the limiting factor for this route of CSF reabsorption.
With an intracranial mass and hypocapnia (group III), Va was greater than Vr early after hypocapnia was begun, but less than Vr at 240 min hypocapnia.
During 240 min of hypocapnia, cumulative intra cranial CSF absorption approximately equalled cu mulative CSF production. Thus, with modest ele vation of CSF pressure providing a modest "driving force" for intracranial reabsorption of CSF (Wood, 1980) , no net reabsorption of intra cranial CSF occurred. As in group II, the presence of an intracranial mass appears to have distorted intracranial absorbance pathways so that conduc tance at intracranial reabsorption sites was im paired. A substantial reduction of intracranial CSF volume ( -1.1 m!) accompanied the reexpansion of CBV (+0.9 ml) during 4 h of hypocapnia. Outflow of CSF from the intracranial to the spinal CSF space and reabsorption of CSF at spinal sites likely accounted for this reduction of intracranial CSF volume. That a large volume of intracranial CSF was reabsorbed via spinal sites with modest eleva tion of intracranial CSF pressure (modest "driving force" for reabsorption) suggests that hypocapnia improved outflow of CSF from the intracranial to the spinal space compared to that observed with an intracranial mass present and normocapnia (group II). Thus, it appears that when an intracranial mass is present, hypocapnia produces sustained lowering of CSF pressure because intracranial CSF gains ac cess to spinal reabsorption sites, and not because hypocapnia improves conductance of intracranial reabsorption sites. The values for CBV observed here are similar to previously reported CBV values, 4.7-5.0 mlllOO g (Lammert sma et aI., 1983a; Powers et aI., 1985; Sakai et aI., 1985; Hawkins et aI., 1986) . Conver sion of previously reported CBV values from ml/l00 g to ml based on a brain weight of 70 g (typ ical brain weight in this study) yields a CBV range of 3.3-3.5 ml, which is in good agreement with the value from this study, 3.4 ± 0.8 ml. The values for CSF volume observed here also are consistent with previously reported values for dog Hornbein, 1986, 1987) . Other findings of the present study that agree with previous reports are (1) Vr during normocapnia was similar to Vr during prolonged hypocapnia (Hochwald et aI., 1976; Martins et aI., 1976; Artru and Hornbein, 1987) ; (2) Vr did not change with time Hornbein, 1986, 1987) ; and (3) Vr at normal CSF pressure was similar to Vr at increased CSF pressure (Wood, 1980) . As Vr remains so constant, only about 0.4 ml of the 1.1-ml increase of intracranial CSF volume that occurred after 10 min of hypocapnia in group I can be accounted for by freshly formed CSF. The balance presumably derived from translocation of CSF from the spinal to the intracranial space.
That brain tissue values from this study were sim ilar to previously reported "control" values (Smith and Marque, 1976; Shigeno et aI., 1982; Bralet et aI., 1983; Chen et aI., 1983a,b; Gotoh et aI., 1985; Hatushita et aI., 1985; Kato et aI., 1986) suggests that hypocapnia and/or intracranial mass did not significantly alter brain tissue water, N a, or K, or cause diffuse, global brain injury. That these values did not differ among the present experimental groups suggests that brain tissue values did not contribute to changes in CSF pressure. That values from the hemisphere with intracranial mass did not differ significantly from values from the hemisphere without intracranial mass suggests that inflation of the balloon did not produce severe, focal brain in jury.
In summary, hypocapnia reduced CBV acutely, but CBV normalized by 4 h, when hypocapnia was continuous. Elevated CSF pressure was lowered by hypocapnia initially because CBV was reduced, then later because intracranial CSF volume de creased. Decrease of intracranial CSF volume did not result from intracranial reabsorption of CSF and probably occurred as a result of improved ac cess of intracranial CSF to spinal sites of reabsorp tion. Brain tissue water and electrolyte contents were not altered by hypocapnia or the presence of an intracranial mass and did not appear to con tribute to changes in CSF pressure.
APPENDIX
Determination of change in CSF volume
According to the formulas of Avezaat et al. (1979, 1980) , in a closed system:
where pCSF is CSF pressure, pCSFe q is a constant equal to pCSF at the equilibration point (i.e., the normal, physiologic steady-state pCSF), E] is the elastance coefficient, a constant defining the slope of the intracranial volume-pressure curve, and V is the change in total volume of the craniospinal com partment. From this equation:
where LlpCSF is the change in pCSF, LlCBV is the change in CBV, and Ll V CSF is the change in CSF volume. At mean pCSF <60 mm Hg, E] is constant (Avezaat et aI., 1979 (Avezaat et aI., , 1980 
Determination of Va
Ll V CSF also is related to the rate of CSF produc tion (Vf) and the rate of CSF reabsorption eVa) by:
where t is time. Va is determined by:
